JAK3 and asthma: On treatment with PI3K and JAK3 inhibitors orally (30 mg/kg), the inflammatory cell counts, such as basophils, neutrophils, macrophages and lymphocytes were reduced to almost normal and p-value was statistically significant in acute (Figures 1A–D; Supplementary Figure 1C and Supplementary Table 1) and chronic model of asthma (Figures 1E–H; Supplementary Figure 1D and Supplementary Table 4), except eosinophil level in acute model (Supplementary Figure 1A).